FOR IMMEDIATE RELEASE Former AbbVie Manager Alleges “AI Whitewashing” Behind R&D “Magic Medicine-Making Machine” as Whistleblower Case Enters New Phase CHICAGO — September 1, 2026 — As pharmaceutical companies race to cast artificial intelligence as the future of drug discovery, a federal whistleblower case against AbbVie is asking an uncomfortable question: what happens when the … Continue reading Former AbbVie Manager Alleges “AI Whitewashing” Behind R&D “Magic Medicine-Making Machine” as Whistleblower Case Enters New Phase